TNF Pharmaceuticals Inc Sustainability Reports
The company was historically a clinical-stage pharmaceutical firm developing therapeutic platforms for age-related and autoimmune diseases. It has recently pivoted its core strategy to focus on energy-efficient blockchain infrastructure, cryptocurrency technology, and quantum-class laser-based computing applications.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 213800CSKAC96ELS4K25
FIGI: BBG001SFSSG4
1 reports from 2024 to 2024